Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review
- 16 December 2009
- journal article
- research article
- Published by Elsevier BV in Lung Cancer
- Vol. 68 (2), 137-145
- https://doi.org/10.1016/j.lungcan.2009.11.008
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Response assessment in solid tumours: a comparison of WHO, SWOG and RECIST guidelinesThe British Journal of Radiology, 2008
- In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceusJournal of Ethnopharmacology, 2007
- Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC)Critical Reviews in Oncology/Hematology, 2006
- Acupuncture-point stimulation for chemotherapy-induced nausea or vomitingPublished by Wiley ,2006
- Astragalus-Based Chinese Herbs and Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Meta-Analysis of Randomized TrialsJournal of Clinical Oncology, 2006
- Screening for lung cancerPublished by Wiley ,2004
- Non–Small-Cell Lung Cancer — Stalemate or Progress?New England Journal of Medicine, 2000
- Lung cancerThe Lancet, 2000
- Karnofsky performance status revisited: reliability, validity, and guidelines.Journal of Clinical Oncology, 1984
- Reporting results of cancer treatmentCancer, 1981